Discover how Morphologically-Directed Raman Spectroscopy (MDRS) on the Morphologi 4-ID can be used to chemically characterize Subvisible Particles (SVPs) in therapeutic proteins.
In this webinar we learn how the FDA have recognised the benefit of utilising Raman spectroscopy, in addition to particle size, shape and count, to characterise SVPs in their native state. This allows a more complete characterization of therapeutic protein products.
Whether you are working in development or QC you will gain understanding on how MDRS complements the current methods for analysing SVPs and enhances product quality and product safety.
発表者
- Dr. Jenny Burt - Senior Applications Specialist, Malvern Panalytical
詳細
Who should attend?
- Scientists and researchers interested in biopharmaceuticals such as injectable drug products and protein therapeutics
- Formulation or quality control scientists who need to control SVPs to ensure product stability and safety
What will you learn?
- Learn how the combination of particle size, shape and chemical identification through MDRS allows comprehensive characterization of SVPs
- Understand why morphological parameters are not always enough to perform root cause analysis